The U.S. drugs and healthcare giant has sent a letter to India#39;s Central Drugs Standard Control Organisation (CDSCO) saying it would "very shortly apply for permission to conduct clinical bridging trials in India," according to the report.from Moneycontrol Business News https://ift.tt/3t5Hrg2
No comments:
Post a Comment